Virtus ETF Advisers LLC Roivant Sciences Ltd. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

A detailed history of Virtus ETF Advisers LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 30,467 shares of ROIV stock, worth $318,075. This represents 0.17% of its overall portfolio holdings.

Number of Shares

30,467

Previous 30,467 -0.0%

Holding current value

$318,075

Previous $322,000 9.01%

% of portfolio

0.17%

Previous 0.16%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$10.36 - $11.74 $39,015 - $44,212	-3,766 Reduced 11.0%	30,467 $322,000
Q1 2024 May 15, 2024	BUY	$9.87 - $11.8 $48,609 - $58,115	4,925 Added 16.8%	34,233 $360,000
Q4 2023 Feb 15, 2024	SELL	$8.38 - $11.58 $17,011 - $23,507	-2,030 Reduced 6.48%	29,308 $329,000
Q3 2023 Nov 07, 2023	SELL	$9.76 - $13.19 $39,537 - $53,432	-4,051 Reduced 11.45%	31,338 $366,000
Q2 2023 Aug 14, 2023	SELL	$7.09 - $10.08 $51,551 - $73,291	-7,271 Reduced 17.04%	35,389 $356,000
Q1 2023 May 15, 2023	BUY	$6.92 - $9.98 $5,224 - $7,534	755 Added 1.8%	42,660 $314,000
Q4 2022 Feb 14, 2023	SELL	$3.36 - $7.99 $71,067 - $168,996	-21,151 Reduced 33.54%	41,905 $334,000
Q3 2022 Nov 14, 2022	BUY	$0.51 - $4.84 $472 - $4,486	927 Added 1.49%	63,056 $203,000
Q2 2022 Aug 12, 2022	BUY	$2.81 - $4.84 $122,468 - $210,941	43,583 Added 235.0%	62,129 $253,000
Q1 2022 May 16, 2022	SELL	$4.74 - $9.91 $5,223 - $10,920	-1,102 Reduced 5.61%	18,546 $92,000
Q4 2021 Feb 14, 2022	BUY	$5.86 - $13.52 $115,137 - $265,640	19,648 New	19,648 $198,000

Others Institutions Holding ROIV

# of Institutions

330

Shares Held

511M

Call Options Held

1.14M

Put Options Held

1.26M

View Full List

About Roivant Sciences Ltd.

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $7.35B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

More about ROIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Roivant Sciences Ltd. Transaction History